Enalapril Maleate and Hydrochlorothiazide (G&W Laboratories, Inc.)
Welcome to the PulseAid listing for the Enalapril Maleate and Hydrochlorothiazide drug offered from G&W Laboratories, Inc.. This Angiotensin Converting Enzyme Inhibitor [EPC],Angiotensin-converting Enzyme Inhibitors [MoA],Decreased Blood Pressure [PE],Increased Diuresis [PE],Thiazide Diuretic [EPC],Thiazides [Chemical/Ingredient] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
| LABELER NAME / MANUFACTURER: | G&W Laboratories, Inc. |
| NON-PROPRIETARY NAME: | Enalapril Maleate and Hydrochlorothiazide |
| SUBSTANCE NAME: | ENALAPRIL MALEATE; HYDROCHLOROTHIAZIDE |
| TYPE: | HUMAN PRESCRIPTION DRUG |
| PHARMA CLASS: | Angiotensin Converting Enzyme Inhibitor [EPC],Angiotensin-converting Enzyme Inhibitors [MoA],Decreased Blood Pressure [PE],Increased Diuresis [PE],Thiazide Diuretic [EPC],Thiazides [Chemical/Ingredient] |
| ROUTE: | ORAL |
| DOSAGE FORM: | TABLET |
| MARKETING CATEGORY NAME: | ANDA |
| START MARKETING DATE: | 2016-03-31 |
| END MARKETING DATE: | 0000-00-00 |
Enalapril Maleate and Hydrochlorothiazide HUMAN PRESCRIPTION DRUG Details:
| Item Description | Enalapril Maleate and Hydrochlorothiazide from G&W Laboratories, Inc. |
| LABELER NAME: | G&W Laboratories, Inc. |
| DEA SCHEDULE: |
|
| ACTIVE STRENGTH: | 5; 12.5(mg/1; mg/1) |
| START MARKETING DATE: | 2016-03-31 |
| END MARKETING DATE: | 0000-00-00 |
| PRODUCT ID: | 0713-1044_fdf382f6-83a4-435c-aec9-a6a26dee23a6 |
| PRODUCT NDC: | 0713-1044 |
| APPLICATION NUMBER: | ANDA075727 |
Other ENALAPRIL MALEATE; HYDROCHLOROTHIAZIDE Pharmaceutical Manufacturers / Labelers:
